Cargando…
The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities
The growth hormone–insulin-like growth factor–insulin-like growth factor binding protein (GH–IGF–IGFBP) axis plays a critical role in the maintenance of normal renal function and the pathogenesis and progression of chronic kidney disease (CKD). Serum IGF-I and IGFBPs are altered with different stage...
Autor principal: | Oh, Youngman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715090/ https://www.ncbi.nlm.nih.gov/pubmed/26889406 http://dx.doi.org/10.1016/j.krcp.2011.12.005 |
Ejemplares similares
-
Relationship of Serum Total Insulin-Like Growth Factor Binding Protein-3 with Insulin-Like Growth Factor-I and Glucose Tolerance in Korean Children and Adolescents
por: Kim, Sun-Young, et al.
Publicado: (2021) -
Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities
por: Gao, Zhumei, et al.
Publicado: (2022) -
Insulin-Like Growth Factor Binding Proteins in Kidney Disease
por: Wang, Shuqiang, et al.
Publicado: (2021) -
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021) -
Delta- like ligand 4- expressing macrophages and human diseases: Insights into pathophysiology and therapeutic opportunities
por: Yuwen, Ya, et al.
Publicado: (2023)